Glucose and glycogen in the diabetic kidney: Heroes or villains?


Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 03 06 2019
revised: 17 07 2019
accepted: 29 07 2019
pubmed: 14 8 2019
medline: 6 2 2020
entrez: 14 8 2019
Statut: ppublish

Résumé

Glucose metabolism in the kidney is currently foremost in the minds of nephrologists, diabetologists and researchers globally, as a result of the outstanding success of SGLT2 inhibitors in reducing renal and cardiovascular disease in individuals with diabetes. However, these exciting data have come with the puzzling but fascinating paradigm that many of the beneficial effects on the kidney and cardiovascular system seem to be independent of the systemic glucose lowering actions of these agents. This manuscript places into context an area of research highly relevant to renal glucose metabolism, that of glycogen accumulation and metabolism in the diabetic kidney. Whether the glycogen that abnormally accumulates is pathological (the villain), is somehow protective (the hero) or is inconsequential (the bystander) is a research question that may provide insight into the link between diabetes and diabetic kidney disease.

Identifiants

pubmed: 31405756
pii: S2352-3964(19)30509-2
doi: 10.1016/j.ebiom.2019.07.067
pmc: PMC6796499
pii:
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Glycogen 9005-79-2
Glucose IY9XDZ35W2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

590-597

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Références

PLoS Comput Biol. 2012;8(6):e1002577
pubmed: 22761565
Diabetes. 1993 Jun;42(6):891-900
pubmed: 8495812
Am J Physiol Endocrinol Metab. 2002 Feb;282(2):E419-27
pubmed: 11788375
J Clin Invest. 1998 Aug 1;102(3):619-24
pubmed: 9691098
Annu Rev Nutr. 2007;27:329-45
pubmed: 17465853
ACS Omega. 2018 Apr 30;3(4):3640-3645
pubmed: 30023874
J Clin Invest. 1993 Apr;91(4):1810-5
pubmed: 8473519
Arch Biochem Biophys. 1979 Oct 1;197(1):310-6
pubmed: 120702
Am J Physiol. 1999 Jan;276(1):E78-84
pubmed: 9886953
Diabetologia. 2017 Feb;60(2):215-225
pubmed: 27878313
J Am Soc Nephrol. 2013 Jul;24(8):1209-14
pubmed: 23723425
Biomacromolecules. 2014 Feb 10;15(2):660-5
pubmed: 24372590
Horm Metab Res. 1980 Feb;12(2):51-5
pubmed: 6245995
Diabetes. 2005 Dec;54(12):3427-34
pubmed: 16306358
Lancet. 2005 Apr 9-15;365(9467):1333-46
pubmed: 15823385
Diabetes. 2011 Sep;60(9):2354-69
pubmed: 21752957
Pediatr Nephrol. 1995 Jun;9(3):287-91
pubmed: 7632512
N Engl J Med. 1992 Sep 3;327(10):707-13
pubmed: 1495524
J Biol Chem. 2014 Dec 19;289(51):35363-75
pubmed: 25339176
Adv Chronic Kidney Dis. 2005 Jan;12(1):5-13
pubmed: 15719328
N Engl J Med. 2016 Jul 28;375(4):323-34
pubmed: 27299675
FASEB J. 1988 Dec;2(15):3097-103
pubmed: 2973423
Nat Rev Nephrol. 2018 Jun;14(6):361-377
pubmed: 29654297
Int J Mol Sci. 2017 Aug 11;18(8):
pubmed: 28800070
Redox Biol. 2016 Dec;10:100-107
pubmed: 27710853
Lab Invest. 1966 Jan;15(1 Pt 2):330-56
pubmed: 5931667
Diabetes Res Clin Pract. 2017 Nov;133:1-9
pubmed: 28866383
Pediatr Nephrol. 1991 Jan;5(1):71-6
pubmed: 2025544
J Forensic Sci. 2017 Jul;62(4):921-925
pubmed: 27982446
Kidney Int. 1999 Mar;55(3):778-92
pubmed: 10027916
Histochem Cell Biol. 2015 Mar;143(3):313-24
pubmed: 25371328
Diabetes Obes Metab. 2000 Dec;2(6):345-50
pubmed: 11225963
Clin Endocrinol (Oxf). 2014 Feb;80(2):208-13
pubmed: 23302039
Diabetologia. 1984 Jul;27(1):32-7
pubmed: 6236120
Hum Mol Genet. 2016 Sep 1;25(17):3784-3797
pubmed: 27436577
Acta Diabetol. 2005 Jun;42(2):110-6
pubmed: 15944846
Diabet Med. 2010 Feb;27(2):136-42
pubmed: 20546255
J Am Soc Nephrol. 2009 Jun;20(6):1293-302
pubmed: 19470684
Peptides. 2013 Apr;42:125-30
pubmed: 23416022
Nat Rev Nephrol. 2018 May;14(5):291-312
pubmed: 29456246
Int J Biol Macromol. 2012 Dec;51(5):887-91
pubmed: 22782068
Clin Sci (Lond). 2015 May 1;128(10):707-13
pubmed: 25583442
Hum Mutat. 2008 Jul;29(7):921-30
pubmed: 18449899
J Forensic Sci. 2013 Jan;58 Suppl 1:S94-8
pubmed: 22971043
Adv Enzymol Relat Subj Biochem. 1956;17:65-134
pubmed: 13313307
Diabetes. 2003 Mar;52(3):596-604
pubmed: 12606498
Mol Metab. 2015 Oct 16;5(1):5-18
pubmed: 26844203
Int J Biol Macromol. 2009 Dec 1;45(5):478-82
pubmed: 19720076
J Comp Pathol. 1990 Feb;102(2):179-90
pubmed: 2324340
Cell Metab. 2017 Jul 5;26(1):17-23
pubmed: 28683284
Diabetologia. 2013 Mar;56(3):675-9
pubmed: 23242170
Diabetes. 2003 Feb;52(2):470-80
pubmed: 12540623
Nephrol Dial Transplant. 2017 Apr 1;32(4):670-676
pubmed: 28407130
Diabetes. 2003 Mar;52(3):581-7
pubmed: 12606496
Nephron. 2001 Jan;87(1):50-7
pubmed: 11174026
Diabetes. 1997 Dec;46(12):1928-38
pubmed: 9392476
Cell Rep. 2019 Apr 30;27(5):1334-1344.e6
pubmed: 31042462
Am J Pathol. 1957 Nov-Dec;33(6):1035-57
pubmed: 13478656
Am J Physiol Endocrinol Metab. 2013 Jan 15;304(2):E117-30
pubmed: 23149623
EMBO J. 2005 Apr 20;24(8):1571-83
pubmed: 15791206
N Engl J Med. 1988 Jan 7;318(1):7-11
pubmed: 3422104
Int J Biochem. 1980;12(1-2):53-4
pubmed: 7399038
Biomacromolecules. 2012 Nov 12;13(11):3805-13
pubmed: 23004915
J Renal Inj Prev. 2013 Jun 01;2(2):73-80
pubmed: 25340133
Carbohydr Polym. 2018 Apr 1;185:145-152
pubmed: 29421051
Exp Mol Med. 2016 Mar 11;48:e219
pubmed: 26964835
Pflugers Arch. 2013 Jan;465(1):39-51
pubmed: 22665048
Nat Commun. 2016 Apr 18;7:11229
pubmed: 27088557
Carbohydr Polym. 2015 Mar 15;118:9-15
pubmed: 25542100
Glycoconj J. 2015 May;32(3-4):113-8
pubmed: 25796617
Mol Cell Endocrinol. 2019 Aug 20;494:110490
pubmed: 31207271
BBA Clin. 2016 Feb 27;5:85-100
pubmed: 27051594

Auteurs

Mitchell A Sullivan (MA)

Glycation and Diabetes Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia. Electronic address: mitchell.sullivan@mater.uq.edu.au.

Josephine M Forbes (JM)

Glycation and Diabetes Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia; Mater Clinical School, School of Medicine, The University of Queensland, St Lucia, Queensland, Australia. Electronic address: josephine.forbes@mater.uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH